Correlation Between Fate Therapeutics and Aldeyra

Can any of the company-specific risk be diversified away by investing in both Fate Therapeutics and Aldeyra at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Fate Therapeutics and Aldeyra into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Fate Therapeutics and Aldeyra, you can compare the effects of market volatilities on Fate Therapeutics and Aldeyra and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Fate Therapeutics with a short position of Aldeyra. Check out your portfolio center. Please also check ongoing floating volatility patterns of Fate Therapeutics and Aldeyra.

Diversification Opportunities for Fate Therapeutics and Aldeyra

0.67

Correlation Coefficient

Fate Therapeutics  Aldeyra

Poor diversification

The 3 months correlation between Fate and Aldeyra is 0.67. Overlapping area represents the amount of risk that can be diversified away by holding Fate Therapeutics and Aldeyra in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Aldeyra and Fate Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Fate Therapeutics are associated (or correlated) with Aldeyra. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Aldeyra has no effect on the direction of Fate Therapeutics i.e., Fate Therapeutics and Aldeyra go up and down completely randomly.

Pair Corralation between Fate Therapeutics and Aldeyra

Given the investment horizon of 90 days Fate Therapeutics is expected to under-perform the Aldeyra. In addition to that, Fate Therapeutics is 1.23 times more volatile than Aldeyra. It trades about -0.07 of its total potential returns per unit of risk. Aldeyra is currently generating about 0.08 per unit of volatility. If you would invest  333.00  in Aldeyra on September 23, 2024 and sell it today you would earn a total of  155.00  from holding Aldeyra or generate 46.55% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Significant
Accuracy	100.0%
Values	Daily Returns

Fate Therapeutics  vs.  Aldeyra

Fate Therapeutics

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Fate Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's basic indicators remain rather sound which may send shares a bit higher in January 2025. The latest tumult may also be a sign of longer-term up-swing for the firm shareholders.

Aldeyra

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Aldeyra has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest unsteady performance, the Stock's fundamental indicators remain strong and the current disturbance on Wall Street may also be a sign of long term gains for the company investors.

Pair Trading with Fate Therapeutics and Aldeyra

The main advantage of trading using opposite Fate Therapeutics and Aldeyra positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Fate Therapeutics position performs unexpectedly, Aldeyra can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Aldeyra will offset losses from the drop in Aldeyra's long position.

The idea behind Fate Therapeutics and Aldeyra pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Analyzer module to portfolio analysis module that provides access to portfolio diagnostics and optimization engine.